Index of artpub/2019/pmc_31512258/

Munir, T
Final analysis from RESONATE : Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
2019
https://ddd.uab.cat/record/223258